. 2015 Jan 29;4(6):808–818. doi: 10.1002/cam4.423

Table 3.

Univariate analyses for several prognostic factors in follicular lymphoma and DLBCL

	Follicular lymphoma				DLBCL (GCB type)
	Stage I–IV		Stage III/IV		Stage I–IV		Stage III/IV
	n	P-value	n	P-value	n	P-value	n	P-value
Gender
Male	32	0.23	26	0.75	21	0.75	15	0.01
Female	45	0.23	25	0.75	19	0.75	8	0.01
Age
<60	42	0.21	30	0.21	15	0.06	9	0.48
≧60	35	0.21	21	0.21	25	0.06	14	0.48
FLIPI/IPI ratio
High/High-in	15	0.05	15	0.05	19	0.7	18	0.71
Low/Low-in	22	0.05	22	0.05	7	0.7	4	0.71
Grade
Grade 1/2	48	0.39	35	0.03	NE	NE	NE	NE
Grade 3	25	0.39	13	0.03	NE	NE	NE	NE
FilGAP
High	12	0.04	8	0.03	10	0.01	6	0.18
Low	65	0.04	43	0.03	30	0.01	17	0.18

DLBCL, diffuse large B-cell lymphoma; GCB, germinal center B-cell-like; FLIPI, Follicular Lymphoma International Prognostic Index; IPI, International Prognostic Index; Low-in, low intermediate; High-in, high intermediate; FilGAP, a Rho GTPase-activating protein (GAP); NE, not examined; n, number of cases.